N/A N=1,704 Radiologic Evaluation and Breast Density (READ)
Breast Cancer
Primary: Mammogram Recall for Additional Imaging — 11.3; 12.3; 9.8 percentage of women recalled
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=1,377 Behavioral and Psychological Impact of Returning Breast Density Results to Latinas
Breast Cancer
Primary: Knowledge of Breast Density as a Masking Factor at First Follow-up — 101; 104; 100 Participants — p=> 0.05
N/A N=507 Study Evaluating Changes In Mammographic Breast Density
Osteoporosis
Primary: Percent Change From Baseline in Mammographic Breast Density at Month 24 — -0.39; -0.05; -0.23; -0.42 percent change
N/A N=1,638 Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
Breast Cancer
Primary: Cancer Detection Rate Per 1000 Women Screened, by Breast Density — 3.2; 12.0; 10.7; 0 cancers per 1000 women screened — p=<0.001
N/A N=128 Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography
Breast Cancer
Primary: Percent Accuracy of Contrast Mammography — 100; 67 percentage of accuracy
N/A N=969 Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
Breast Cancer
Primary: Diagnostic Yield — 3.2; 9.6; 10.7 cancers per 1000 women screened — p=.016
Phase 2 N=30 Denosumab and MRI Breast Imaging
Breast Cancer
Primary: Relative Change of ≥ 5% in Breast Density at 6 Months — 13; 8; 4 Participants — p=0.026
N/A N=995 ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2
Breast Density · Breast Cancer Female
Primary: Number of Participants Taking Chemoprevention at 12 Months — 1; 1 Participants
N/A N=2,978 Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue
Breast Carcinoma
Primary: Rate of Detection of Invasive Cancers — 9; 14 Participants
N/A N=6,266 Assessment of Periodic Screening of Women With Denser Breast Using WBUS and DBT
Breast Cancer
Primary: Cancer Yield Per 1,000 — 5.0; 6.3; 4.9; 5.9 Cancer yield per 1,000 — p=0.005
N/A N=517 KEEPS Mammographic Density And Breast Health Ancillary Study
Mammographic Density · Abnormal Mammogram
Primary: BIRADS Breast Density — 9; 9; 15; 42 participants
Phase 3 N=51 Olive Oil for High Risk Breast Cancer Prevention in Women
Breast Cancer
Primary: Change in Maximum Volumetric Breast Density Percentage — -0.038 Mean decrease in max VBD percentage
N/A N=45 ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer
Breast Cancer
Primary: Correlation of Peak Displacement (PD) for Detecting Malignancy — 4.5803; 8.628 microns — p=0.2988
N/A N=1,232 Acquisition of Breast Mammography Images
Breast Cancer
Primary: Number of Participants for Whom Study Image Data Were Collected — 642; 124; 244 Participants
N/A N=72 Breast Displacement and CT Radiation Dose
Computed Tomography · Radiation Dosage
Primary: Skin Entrance Radiation Dose During Computed Tomography (CT) — 1775; 1325; 625; 259 mrad
Phase 2 N=42 Karolinska Interventional Study of Mammograhic Density (Karisma-1)
Breast Cancer · Mammographic Density
Primary: Mammographic Breast Density — -3.3; -2.5 percentage of breast area
Phase 2 N=321 Soy Protein and Breast Cancer Risk Reduction
Breast Cancer
Primary: Mammographic Density (Baseline) — 29.21; 28.24 percentage of glandular tissue in breast
N/A N=162 Tumor: Breast Ratio Study
Breast Cancer · LCIS · DCIS
Primary: Quality of Life as Measured by the Breast Q — 61.9; 57.6; 74.2; 64.2 score on a scale
Phase 2 N=197 Soy Isoflavones and Breast Cancer Risk Reduction
Breast Cancer
Primary: Fibroglandular Tissue in Total Breast (FGBT%) — 24.94; 25.34; 24.03; 25.82 percentage of total breast tissue — p=0.071
N/A N=28 Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study
Breast Screening
Primary: Ratio of Intensity Score of Normal Breast Tissue for Left Breast Tissue Compared to Right for T1 Imaging Sequence — 1.07 ratio
N/A N=107 Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM)
Breast Cancer
Primary: FFDM (Full Field Digital Mammography) Mammogram Scores — 12; 0 FFDM Mammogram set
Phase 2 N=158 Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast
Mammographically Dense Breast
Primary: Mammographic Breast Density Using Cumulus Software — -6.30; -5.77; -2.81; -5.43 Percent Change in Breast Density
Phase 1 N=82 Effect of Denosumab on Cellular Biomarkers in the Human Breast
Healthy Volunteer, Female, Breast
Primary: Log Ratio of Post-baseline to Baseline Ki-67 Index in Mammary Epithelial Cells — 0.084; -0.100; -0.081 log ratio — p=0.2966
N/A N=496 Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
Breast Cancer
Primary: Detection of Breast Cancer (Sensitivity)
Phase 2 N=46 Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
Breast Neoplasms
Primary: Percent Change in Mammographic Density at 1 Year on Exemestane — -2.4 percent change from baseline
N/A N=1,085 Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment
Breast Abnormalities
Primary: Number of Participants Without Cancer Who Were Recalled — 274 participants
N/A N=20 Tactile Breast Imaging Sensor for Tumor Malignancy Characterization
Breast Cancer
Primary: Size Error in Millimeters — 0 milimeters
N/A N=298 Diagnostic US for Reduction of Benign Breast Biopsies Using US-guided Optical Tomography
Breast Biopsy
Primary: Impact of US-guided DOT on the Potential Reduction of Benign Biopsies as Measured by Comparing the Reads With a Non- Suspicious Assessment of Conventional Imaging (CI)…
N/A N=558 Comparison of Full-Field Digital Mammography With Digital Breast Tomography for Screening Call-Back Rates
Breast Neoplasms
Primary: Recall Rate in Group A Participants — 29; 34; 472; 467 Participants — p=0.46
N/A N=1,681 Ultrasound Elastography of Breast Lesions
Breast Neoplasms
Primary: Estimates of Effect of Selectively Upgrading BIRADS Category 3 and Downgrading BIRADS 4a Masses Based on SWE Features. Overall Specificity and Sensitivity of BI-RADS…